[1]
2026. Evaluation of Hematological Inflammatory Markers in Differentiating Benign from Malignant Endometrial Lesions in Women with Abnormal Uterine Bleeding. Annals of the College of Medicine Mosul. 48, 1 (Jul. 2026), 100–105. DOI:https://doi.org/10.33899/acmm.v48.i1.62889.